Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10770 - University of Cincinnati
mi
from
Cincinnati, OH
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10770 - University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10773
mi
from
Cleveland, OH
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10773
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13278 - OhioHealth Research Institute
mi
from
Columbus, OH
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13278 - OhioHealth Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10785 - Lehigh Valley Hospital
mi
from
Allentown, PA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10785 - Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13261 - University of Pennsylvania
mi
from
Philadelphia, PA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13261 - University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10767 - Temple University Hospital
mi
from
Philadelphia, PA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10767 - Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13277
mi
from
Philadelphia, PA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13277
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10774 - University of Pittsburgh
mi
from
Pittsburgh, PA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10774 - University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation
mi
from
Germantown, TN
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation
mi
from
Germantown, TN
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13024 - Austin Heart, PLLC
mi
from
Austin, TX
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13024 - Austin Heart, PLLC
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute
mi
from
Dallas, TX
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10755 - Texas Heart Institute
mi
from
Houston, TX
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10755 - Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13268 - Houston Methodist Hospital
mi
from
Houston, TX
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13268 - Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10763 - University Hospital
mi
from
Salt Lake City, UT
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10763 - University Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center
mi
from
Seattle, WA
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10764 - University of Wisconsin
mi
from
Madison, WI
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10764 - University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10769 - Aurora Healthcare
mi
from
Milwaukee, WI
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10769 - Aurora Healthcare
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 13279
mi
from
Milwaukee, WI
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 13279
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 10789 - Aspirus Research Institute
mi
from
Wausau, WI
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 10789 - Aspirus Research Institute
mi
from
Wausau, WI
Click here to add this to my saved trials
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated:  12/31/1969
Mesoblast Investigational Site 11027
mi
from
Edmonton,
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Status: Enrolling
Updated: 12/31/1969
Mesoblast Investigational Site 11027
mi
from
Edmonton,
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Sutter Eden Medical Center
mi
from
Castro Valley, CA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Sutter Eden Medical Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Southern California Permanente Medical Group
mi
from
Los Angeles, CA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Southern California Permanente Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
UCSD Medical Center
mi
from
San Diego, CA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
UCSD Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
WellStar Health System
mi
from
Marietta, GA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
WellStar Health System
mi
from
Marietta, GA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Cadence Health, Northwestern Medicine Central DuPage Hospital
mi
from
Winfield, IL
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Cadence Health, Northwestern Medicine Central DuPage Hospital
mi
from
Winfield, IL
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Baptist Health Lexington
mi
from
Lexington, KY
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Baptist Health Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Medical Center
mi
from
Lexington, KY
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
St John Hospital & Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
SSM DePaul Health Center
mi
from
Bridgeton, MO
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
SSM DePaul Health Center
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University Hospital of Cincinnati
mi
from
Cincinnati, OH
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University Hospital of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Tennessee Interventional Associates
mi
from
Chattanooga, TN
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Tennessee Interventional Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Multicare Medical Center
mi
from
Tacoma, WA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Multicare Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts Worcester
mi
from
Worcester, MA
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts Worcester
mi
from
Worcester, MA
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
Valley Baptist Harlingen
mi
from
Harlingen, TX
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
Valley Baptist Harlingen
mi
from
Harlingen, TX
Click here to add this to my saved trials
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Post Market Surveillance Study of the Wingspan Stent System
WEAVE™ Trial: Wingspan StEnt System Post MArket SurVEillance Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Status: Enrolling
Updated:  12/31/1969
UPMC Heart and Vascular Institute - Division of Vascular Surgery
mi
from
Pittsburgh, PA
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Status: Enrolling
Updated: 12/31/1969
UPMC Heart and Vascular Institute - Division of Vascular Surgery
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Point of Care (POC) Biomarkers of Ischemia
Point of Care (POC) Biomarkers of Ischemia
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealtlh University Health Systems
mi
from
Richmond, VA
Point of Care (POC) Biomarkers of Ischemia
Point of Care (POC) Biomarkers of Ischemia
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealtlh University Health Systems
mi
from
Richmond, VA
Click here to add this to my saved trials
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Biological Mechanisms of Vascular Dysfunction With Age and Estrogen Deficiency
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
Biological Mechanisms of Vascular Dysfunction With Age and Estrogen Deficiency
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials